BLOG

investors

Rocket Pharmaceuticals Surges To 5-Year High On Promising Gene Therapy

Rocket Pharmaceuticals (RCKT) announced positive Phase 1 test results for a gene therapy in heart disease — prompting RCKT stock to surge Wednesday.